Company receives possession of Tarapur manufacturing facility under asset transfer
Anuh Pharma has received possession of a manufacturing facility of M/s. Vanquest Pharma at M.I.D.C., Tarapur, Boisar, District Palghar, Maharashtra ✅ Follows an Asset Transfer Agreement executed on 16th October, 2026.
By ScoutQuest · · 1 min read
- Facility Location
- F-10, M.I.D.C., Tarapur, Boisar, District Palghar – 401506, Maharashtra
- Asset Transfer Agreement Date
- 16th October, 2026
- Transaction Terms
- no material changes to the details of the transaction as disclosed in the initial intimation
Possession of the plant has changed hands
Anuh Pharma Limited has received possession of a manufacturing facility belonging to M/s. Vanquest Pharma Private Limited. The facility is at F-10, M.I.D.C., Tarapur, Boisar, District Palghar – 401506, Maharashtra.
The handover is part of an Asset Transfer Agreement executed on 16th October, 2026. The company had informed the exchanges about the transaction on that same date, and this update says it has now taken possession of the site.
The update also states that there are no material changes to the details of the transaction as disclosed in the initial intimation of 16th October, 2026.
What possession means
- In an asset transfer, the buyer typically gets the asset physically handed over before other formal steps are completed.
- Receiving possession is an operational milestone: the company now has the site in hand.
- It is a step in the transaction, not a statement about production, sales or earnings from that site.
What to keep in view
- The intimation is a possession update. For the transaction's commercial details, the company points to its initial intimation dated 16th October, 2026.
- The update records the location of the facility and the agreement date. It does not describe the products made at the site or its capacity.
- The company has confirmed there are no changes to the earlier disclosed terms of the deal.
The update is a disclosure of a completed step in an asset purchase, and the company has kept the earlier transaction details unchanged.
Also from Anuh Pharma
Signs Asset Transfer Agreement to buy Vanquest Pharma's Tarapur manufacturing facility
16 Oct 2026
Board approves investment in manufacturing assets; clears proposal to avail loan of up to ₹ 75 crs
13 Oct 2026
Board approves investment in manufacturing assets for capacity expansion, proposal to avail loan of up to ₹ 75 crs
13 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.